Sangamo BioSciences Announces Presentation At The 35th Annual J.P. Morgan Healthcare Conference
RICHMOND, Calif., Jan. 4, 2017 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced today that Sandy Macrae, M.B., Ch.B., Ph.D, Sangamo's chief executive officer, will participate in the 35th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11th at 4:30 p.m. Pacific Time in San Francisco, California.
To access the live webcast, please visit the Investor and Media section of the Sangamo website, www.sangamo.com. The presentation will be archived on the Sangamo website for two weeks after the event.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sangamo-biosciences-announces-presentation-at-the-35th-annual-jp-morgan-healthcare-conference-300385667.html
SOURCE Sangamo BioSciences, Inc.
Released January 4, 2017